Pharmaceutical companies have harnessed its power by developing GLP-1s, mimicking its effects
1 Introduction Liver disease represents a major global health challenge with diverse etiologies, including viral infections (hepatitis B and C), alcohol abuse, metabolic disorders (Metabolic Dysfunction-Associated Steatotic Liver Disease, MASLD), drug- and toxin-induced injuries, and autoimmune hepatitis
Pickart 2015 documented accelerated wound healing across rabbit, rat, mouse, and pig models, including improved outcomes in diabetic and ischemic wounds through reduced TNF-alpha expression and increased collagen output
However, these should complement, not replace, prescribed fever medicine
Any changes in the rats body composition were measured by time-domain nuclear magnetic resonance (TD NMR), as well as through the collection of organ and muscle tissue [3]